Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
There is no evidence or record of “cytoplasmic polyadenylated homeobox like” or its listed aliases as a valid or recognized gene, protein, or molecular target in major genomic, pharmacological, or protein databases. The most closely named gene is “Cytoplasmic polyadenylated homeobox like 2” (CPHXL2) which is a protein-coding gene predicted to act as a DNA-binding transcription factor[1]. However, “CPHXL” does not correspond to a known or distinct molecule, indicating a likely misidentification, misspelling, or the use of a placeholder name. If you have additional context (such as a reference sequence, organism, or literature citation), it may enable a more precise identification. Otherwise, this designation does not correspond to a real molecular target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytoplasmic polyadenylated homeobox like (CPHXL).